147 related articles for article (PubMed ID: 27803312)
21. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies.
Bansal M; Farrugia A; Balboni S; Martin G
Curr Drug Saf; 2013 Sep; 8(4):236-45. PubMed ID: 23909705
[TBL] [Abstract][Full Text] [Related]
22. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements.
Hans GA; Ledoux D; Roediger L; Hubert MB; Koch JN; Senard M
J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):328-32. PubMed ID: 25440623
[TBL] [Abstract][Full Text] [Related]
23. Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.
Raiman M; Mitchell CG; Biccard BM; Rodseth RN
Eur J Anaesthesiol; 2016 Jan; 33(1):42-8. PubMed ID: 26351826
[TBL] [Abstract][Full Text] [Related]
24. Hydroxyethyl starch for resuscitation.
Haase N; Perner A
Curr Opin Crit Care; 2013 Aug; 19(4):321-5. PubMed ID: 23743591
[TBL] [Abstract][Full Text] [Related]
25. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
Perel P; Roberts I; Ker K
Cochrane Database Syst Rev; 2013 Feb; (2):CD000567. PubMed ID: 23450531
[TBL] [Abstract][Full Text] [Related]
26. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.
Hand WR; Whiteley JR; Epperson TI; Tam L; Crego H; Wolf B; Chavin KD; Taber DJ
Anesth Analg; 2015 Mar; 120(3):619-626. PubMed ID: 25036375
[TBL] [Abstract][Full Text] [Related]
27. Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007-2010).
Hayes G; Benedicenti L; Mathews K
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):35-40. PubMed ID: 26587795
[TBL] [Abstract][Full Text] [Related]
28. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality.
Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee
Intensive Care Med; 2011 May; 37(5):816-23. PubMed ID: 21308360
[TBL] [Abstract][Full Text] [Related]
29. Renal Morbidity of 6% Hydroxyethyl Starch 130/0.4 in 9000 Propensity Score Matched Pairs of Surgical Patients.
Miyao H; Kotake Y
Anesth Analg; 2020 Jun; 130(6):1618-1627. PubMed ID: 31856004
[TBL] [Abstract][Full Text] [Related]
30. Effects of resuscitation with human albumin 5%, hydroxyethyl starch 130/0.4 6%, or crystalloid on kidney damage in an ovine model of septic shock.
Kampmeier TG; Arnemann PH; Hessler M; Bockbreder K; Wald A; Morelli A; Rehberg SW; Ertmer C
Br J Anaesth; 2018 Sep; 121(3):581-587. PubMed ID: 30115256
[TBL] [Abstract][Full Text] [Related]
31. CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients.
Hartog C; Reinhart K
Intensive Care Med; 2009 Aug; 35(8):1337-42. PubMed ID: 19533093
[TBL] [Abstract][Full Text] [Related]
32. Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: A systematic review and stratified meta-analysis.
Rasmussen KC; Secher NH; Pedersen T
Medicine (Baltimore); 2016 Aug; 95(31):e4498. PubMed ID: 27495098
[TBL] [Abstract][Full Text] [Related]
33. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.
Patel A; Waheed U; Brett SJ
Intensive Care Med; 2013 May; 39(5):811-22. PubMed ID: 23430019
[TBL] [Abstract][Full Text] [Related]
34. [Limited applications for hydroxyethyl starch : background and alternative concepts].
Rehm M
Anaesthesist; 2013 Aug; 62(8):644-55. PubMed ID: 23925465
[TBL] [Abstract][Full Text] [Related]
35. Retrospective evaluation of paired plasma creatinine and chloride concentrations following hetastarch administration in anesthetized dogs (2002-2015): 244 cases.
Zersen KM; Mama K; Mathis JC
J Vet Emerg Crit Care (San Antonio); 2019 May; 29(3):309-313. PubMed ID: 31066159
[TBL] [Abstract][Full Text] [Related]
36. Lack of Association between Low Cumulative Dose of Hydroxyethyl Starch and Acute Kidney Injury in Patients with Acute Ischemic Stroke.
Park SH; Kim TJ; Jeong HB; Ko SB
J Korean Med Sci; 2020 Oct; 35(40):e325. PubMed ID: 33075852
[TBL] [Abstract][Full Text] [Related]
37. Fluid replacement with hydroxyethyl starch in critical care--a reassessment.
Hartog CS; Welte T; Schlattmann P; Reinhart K
Dtsch Arztebl Int; 2013 Jun; 110(26):443-50. PubMed ID: 23885279
[TBL] [Abstract][Full Text] [Related]
38. The impact of crystalloid and colloid infusion on the kidney in rodent sepsis.
Schick MA; Isbary TJ; Schlegel N; Brugger J; Waschke J; Muellenbach R; Roewer N; Wunder C
Intensive Care Med; 2010 Mar; 36(3):541-8. PubMed ID: 19890625
[TBL] [Abstract][Full Text] [Related]
39. Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double-blind clinical trial.
Béchir M; Puhan MA; Fasshauer M; Schuepbach RA; Stocker R; Neff TA
Crit Care; 2013 Dec; 17(6):R299. PubMed ID: 24365167
[TBL] [Abstract][Full Text] [Related]
40. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.
He B; Xu B; Xu X; Li L; Ren R; Chen Z; Xiao J; Wang Y; Xu B
Crit Care; 2015 Mar; 19(1):92. PubMed ID: 25886952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
